177 related articles for article (PubMed ID: 12747295)
1. Efficacy of thalidomide in refractory adult Still's disease: a new case report.
Meaux-Ruault N; Magy N; Gil H; Dupond JL
Clin Exp Rheumatol; 2003; 21(2):272. PubMed ID: 12747295
[No Abstract] [Full Text] [Related]
2. TNFalpha and response of treatment-resistant adult-onset Still's disease to thalidomide.
Stambe C; Wicks IP
Lancet; 1998 Aug; 352(9127):544-5. PubMed ID: 9716064
[No Abstract] [Full Text] [Related]
3. Adalimumab in the treatment of refractory adult-onset Still's disease.
Lee WS; Yoo SH; Ko RE; Yoo WH
Int J Rheum Dis; 2017 Nov; 20(11):1798-1799. PubMed ID: 24954877
[No Abstract] [Full Text] [Related]
4. Prolonged efficacy of infliximab for refractory adult-onset Still's disease.
Dilhuydy MS; Vatan R; Etienne G; Longy-Boursier M; Mercié P
Clin Exp Rheumatol; 2005; 23(1):121-2. PubMed ID: 15789901
[No Abstract] [Full Text] [Related]
5. Successful treatment of a patient with refractory adult Still's disease by tacrolimus.
Murakami K; Fujii T; Yukawa N; Yoshifuji H; Kawabata D; Tanaka M; Usui T; Mimori T
Mod Rheumatol; 2007; 17(2):167-70. PubMed ID: 17437176
[TBL] [Abstract][Full Text] [Related]
6. Blockade of interleukin 1 receptor in Still's disease affects activation of peripheral T-lymphocytes.
Youssef J; Lazaro E; Blanco P; Viallard JF
J Rheumatol; 2008 Dec; 35(12):2453-6. PubMed ID: 19143047
[No Abstract] [Full Text] [Related]
7. Successful treatment with tacrolimus of refractory adult-onset Still's disease.
Ohe M; Oku K; Kono M; Bohgaki T
Korean J Intern Med; 2014 Mar; 29(2):259-61. PubMed ID: 24648814
[No Abstract] [Full Text] [Related]
8. Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report.
Benucci M; Li GF; Del Rosso A; Manfredi M
Clin Exp Rheumatol; 2005; 23(5):733. PubMed ID: 16173267
[No Abstract] [Full Text] [Related]
9. Anti-Golgi antibodies in adult Still's disease.
Staub HL; Souza F; Chan EK; von Mühlen CA
Clin Exp Rheumatol; 2003; 21(2):275-6. PubMed ID: 12747298
[No Abstract] [Full Text] [Related]
10. Exacerbation of adult-onset Still's disease, possibly related to elevation of serum tumor necrosis factor-alpha after etanercept administration.
Kaneko K; Kaburaki M; Muraoka S; Tanaka N; Yamamoto T; Kusunoki Y; Abe H; Endo H; Kawai S
Int J Rheum Dis; 2010 Oct; 13(4):e67-9. PubMed ID: 21199457
[TBL] [Abstract][Full Text] [Related]
11. Autophagy inhibition in adult-onset Still's disease: still more space for hydroxychloroquine?
Papagoras C; Chrysanthopoulou A; Mitsios A; Arampatzioglou A; Ritis K; Skendros P
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):133-134. PubMed ID: 29148405
[No Abstract] [Full Text] [Related]
12. Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade.
Rech J; Ronneberger M; Englbrecht M; Finzel S; Katzenbeisser J; Manger K; Manger B; Schett G
Ann Rheum Dis; 2011 Feb; 70(2):390-2. PubMed ID: 20650873
[No Abstract] [Full Text] [Related]
13. [Biological treatment of rare inflammatory rheumatic diseases].
Baslund B
Ugeskr Laeger; 2008 Jun; 170(24):2150-2. PubMed ID: 18565301
[TBL] [Abstract][Full Text] [Related]
14. IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease.
Naumann L; Feist E; Natusch A; Langen S; Krause A; Buttgereit F; Burmester GR
Ann Rheum Dis; 2010 Feb; 69(2):466-7. PubMed ID: 20107032
[No Abstract] [Full Text] [Related]
15. IL-1 Trap rilonacept in refractory adult onset Still's disease.
Petryna O; Cush JJ; Efthimiou P
Ann Rheum Dis; 2012 Dec; 71(12):2056-7. PubMed ID: 22679302
[No Abstract] [Full Text] [Related]
16. Pathogenesis and management of adult-onset Still's disease.
Efthimiou P; Georgy S
Semin Arthritis Rheum; 2006 Dec; 36(3):144-52. PubMed ID: 16949136
[TBL] [Abstract][Full Text] [Related]
17. Infliximab in the treatment of adult Still's disease refractory to conventional therapy.
Cavagna L; Caporali R; Epis O; Bobbio-Pallavicini F; Montecucco C
Clin Exp Rheumatol; 2001; 19(3):329-32. PubMed ID: 11407090
[TBL] [Abstract][Full Text] [Related]
18. [Infliximab (anti-TNF-alpha) treatment in patients with adult Still's disease. Experience in 2 cases].
Bonilla Hernán MG; Cobo Ibáñez T; de Miguel Mendieta E; Martín-Mola E
An Med Interna; 2004 Jan; 21(1):23-6. PubMed ID: 15195482
[TBL] [Abstract][Full Text] [Related]
19. Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases.
Fautrel B; Sibilia J; Mariette X; Combe B;
Ann Rheum Dis; 2005 Feb; 64(2):262-6. PubMed ID: 15184196
[TBL] [Abstract][Full Text] [Related]
20. Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?
Efthimiou P; Kontzias A; Ward CM; Ogden NS
Nat Clin Pract Rheumatol; 2007 Jun; 3(6):328-35. PubMed ID: 17538564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
